[HTML][HTML] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European …

A Angelis, A Lange, P Kanavos - The European Journal of Health …, 2018 - Springer
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

A Aris, A Lange, K Panos - The European Journal of Health …, 2018 - search.proquest.com
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

A Angelis, A Lange, P Kanavos - The European Journal of …, 2018 - econpapers.repec.org
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

[PDF][PDF] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European …

A Angelis, A Lange, P Kanavos - 2017 - core.ac.uk
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

A Angelis, A Lange, P Kanavos - The European Journal of Health …, 2018 - ideas.repec.org
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

A Angelis, A Lange, P Kanavos - The European Journal of Health …, 2018 - JSTOR
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

[引用][C] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European …

A Angelis, A Lange, P Kanavos - The European Journal of Health …, 2017 - cir.nii.ac.jp
Using health technology assessment to assess the value of new medicines: results of a
systematic review and expert consultation across eight European countries | CiNii Research …

[HTML][HTML] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European …

A Angelis, A Lange, P Kanavos - The European Journal of Health …, 2018 - ncbi.nlm.nih.gov
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

[PDF][PDF] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European …

A Angelis, A Lange, P Kanavos - 2017 - researchgate.net
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

A Angelis, A Lange, P Kanavos - European Journal of Health …, 2018 - eprints.lse.ac.uk
Although health technology assessment (HTA) systems base their decision making process
either on economic evaluations or comparative clinical benefit assessment, a central aim of …